Ignite Creation Date:
2025-12-25 @ 12:31 AM
Ignite Modification Date:
2026-01-05 @ 12:11 AM
Study NCT ID:
NCT03733067
Status:
WITHDRAWN
Last Update Posted:
2023-12-04
First Post:
2018-11-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy of Abatacept for Treating Chronic Cytopenia in Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) Haploinsufficiency
Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-30
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-30
Completion Date Type:
ACTUAL
First Submit Date:
2018-11-06
First Submit QC Date:
None
Study First Post Date:
2018-11-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-30
Last Update Post Date:
2023-12-04
Last Update Post Date Type:
ACTUAL